Pacing and defibrillators in complex congenital heart disease

Henry Chubb, Mark O'Neill, Eric Rosenthal*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)


Device therapy in the complex congenital heart disease (CHD) population is a challenging field. There is a myriad of devices available, but none designed specifically for the CHD patient group, and a scarcity of prospective studies to guide best practice. Baseline cardiac anatomy, prior surgical and interventional procedures, existing tachyarrhythmias and the requirement for future intervention all play a substantial role in decision making. For both pacing systems and implantable cardioverter defibrillators, numerous factors impact on the merits of system location (endovascular versus non-endovascular), lead positioning, device selection and device programming. For those with Fontan circulation and following the atrial switch procedure there are also very specific considerations regarding access and potential complications. This review discusses the published guidelines, device indications and the best available evidence for guidance of device implantation in the complex CHD population.

Original languageEnglish
Pages (from-to)57-64
Number of pages8
JournalArrhythmia and Electrophysiology Review
Issue number1
Publication statusPublished - 1 Jun 2016


  • Arrhythmia
  • Cardiac resynchronisation therapy
  • Congenital heart disease
  • Implantable cardioverter defibrillator
  • Pacing
  • Sudden cardiac death


Dive into the research topics of 'Pacing and defibrillators in complex congenital heart disease'. Together they form a unique fingerprint.

Cite this